If you made any changes in Pure, your changes will be visible here soon.

Research Output 1971 2019

Filter
Review article
2019
2 Citations (Scopus)

Cancer and the dopamine D2 receptor: A pharmacological perspective

Weissenrieder, J. S., Neighbors, J., Mailman, R. & Hohl, R., Jan 1 2019, In : Journal of Pharmacology and Experimental Therapeutics. 370, 1, p. 111-126 16 p.

Research output: Contribution to journalReview article

Dopamine D2 Receptors
Pharmacology
Neoplasms
Ligands
Drug Therapy
2017
41 Citations (Scopus)

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Arnsten, A. F. T., Girgis, R. R., Gray, D. L. & Mailman, R. B., Jan 1 2017, In : Biological Psychiatry. 81, 1, p. 67-77 11 p.

Research output: Contribution to journalReview article

Prefrontal Cortex
Dopamine
Schizophrenia
Short-Term Memory
Therapeutics
2014
16 Citations (Scopus)

Dopamine D1receptor signaling: Does GαQ-phospholipase C actually play a role?

Lee, S. M., Yang, Y. & Mailman, R. B., Oct 1 2014, In : Journal of Pharmacology and Experimental Therapeutics. 351, 1, p. 9-17 9 p.

Research output: Contribution to journalReview article

Type C Phospholipases
Dopamine
Adenylyl Cyclases
Azepines
Benzazepines
2010
154 Citations (Scopus)

Third generation antipsychotic drugs: Partial agonism or receptor functional selectivity?

Mailman, R. & Murthy, V., Mar 22 2010, In : Current Pharmaceutical Design. 16, 5, p. 488-501 14 p.

Research output: Contribution to journalReview article

Drug Partial Agonism
Drug Receptors
Antipsychotic Agents
olanzapine
Pharmaceutical Preparations
2007
778 Citations (Scopus)

Functional selectivity and classical concepts of quantitative pharmacology

Urban, J. D., Clarke, W. P., Von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., Miller, K. J., Spedding, M. & Mailman, R. B., Jan 5 2007, In : Journal of Pharmacology and Experimental Therapeutics. 320, 1, p. 1-13 13 p.

Research output: Contribution to journalReview article

Pharmacology
Ligands
Adrenergic Receptors
Vasopressin Receptors
Serotonin Receptors
2006
26 Citations (Scopus)

D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinsons' disease

Lewis, M., Huang, X., Nichols, D. E. & Mailman, R., Jun 1 2006, In : CNS and Neurological Disorders - Drug Targets. 5, 3, p. 345-353 9 p.

Research output: Contribution to journalReview article

Dopamine Agonists
Levodopa
Neuroprotective Agents
Parkinson Disease
Dopamine D2 Receptors
2001
44 Citations (Scopus)

Parkinson's disease and D1 dopamine receptors

Mailman, R., Huang, X. & Nichols, D. E., Dec 4 2001, In : Current Opinion in Investigational Drugs. 2, 11, p. 1582-1591 10 p.

Research output: Contribution to journalReview article

Dopamine D1 Receptors
Parkinson Disease
Pharmaceutical Preparations
Parkinsonian Disorders
Levodopa
2000
23 Citations (Scopus)

Developing novel antipsychotic drugs: Strategies and goals

Miyamoto, S., Duncan, G. E., Mailman, R. & Lieberman, J. A., 2000, In : Current Opinion in Central and Peripheral Nervous System Investigational Drugs. 2, 1, p. 25-39 15 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
1998
178 Citations (Scopus)

Serotonergic basis of antipsychotic drug effects in schizophrenia

Lieberman, J. A., Mailman, R., Duncan, G., Sikich, L., Chakos, M., Nichols, D. E. & Kraus, J. E., Dec 1 1998, In : Biological Psychiatry. 44, 11, p. 1099-1117 19 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Serotonin
Schizophrenia
Serotonin Receptors
Hallucinogens
1987
10 Citations (Scopus)

Neurotoxicants and central catecholamine systems

Mailman, R. & Lewis, M. H., Jan 1 1987, In : NeuroToxicology. 8, 1, p. 123-140 18 p.

Research output: Contribution to journalReview article

Catecholamines
Erythrosine
Polydipsia
Neurochemistry
Environmental Pollutants
1986
32 Citations (Scopus)

The multiplicity of the D1 dopamine receptor.

Mailman, R., Schulz, D. W., Kilts, C. D., Lewis, M. H., Rollema, H. & Wyrick, S., Dec 1 1986, In : Advances in experimental medicine and biology. 204, p. 53-72 20 p.

Research output: Contribution to journalReview article

Brain Chemistry
Benzazepines
Dopamine D1 Receptors
Animal Behavior
Dopamine Antagonists
1981
19 Citations (Scopus)

Effects of TRH on central nervous system function.

Breese, G. R., Mueller, R. A., Mailman, R. & Frye, G. D., Dec 1 1981, In : Progress in clinical and biological research. 68, p. 99-116 18 p.

Research output: Contribution to journalReview article

Neurotransmitter Agents
Central Nervous System
Peptide Receptors
Brain
Cholinergic Agents
1978
8 Citations (Scopus)

An alternative to animal models of central nervous system disorders: Study of drug mechanisms and disease symptoms in animals

Breese, G. R., Mueller, R. A., Mailman, R., Frye, G. D. & Vogel, R. A., Jan 1 1978, In : Progress in Neuro-Psychopharmacology. 2, 3, p. 313-325 13 p.

Research output: Contribution to journalReview article

Central Nervous System Diseases
Animal Models
Pharmaceutical Preparations
Research
13 Citations (Scopus)

Importance of dopaminergic pathways and other neural systems to behavior and action of psychotropic drugs

Breese, G. R., Mueller, R. A., Hollister, A. & Mailman, R., Jan 1 1978, In : Federation Proceedings. 37, 10, p. 2429-2433 5 p.

Research output: Contribution to journalReview article

Hydroxydopamines
Neural Pathways
Animal Behavior
Psychotropic Drugs
Dopamine Receptors